Featured Research

from universities, journals, and other organizations

American Society of Clinical Oncology issues annual report on progress against cancer

Date:
December 5, 2011
Source:
American Society of Clinical Oncology
Summary:
The American Society of Clinical Oncology has released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year. The report also identifies the most promising trends in oncology and provides insights from experts on where the future of cancer care is heading.

The American Society of Clinical Oncology (ASCO) has released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year. The report also identifies the most promising trends in oncology and provides insights from experts on where the future of cancer care is heading.

"We've made significant strides in clinical cancer research over the past year and this report adds renewed hope for patients," said Nicholas J. Vogelzang, MD, Co-Executive Editor of the report. "More personalized treatment approaches and advances in early detection are helping patients live longer, healthier lives. But we must improve the nation's clinical research system and expand access to quality cancer care to accelerate the pace of progress."

This year's top research advances demonstrate new therapies for reducing cancer recurrence, progress made against hard-to-treat cancers, and improvements in cancer prevention and screening. The report also highlights several new drug approvals that bring smarter, more effective therapies to specific genetic subgroups of patients with cancer. The top five advances selected by the editors are:

  • A Phase III study finding that vemurafenib (Zelboraf), which targets a common mutation in melanoma in a gene called BRAF, improved overall survival in patients with advanced melanoma when compared to standard chemotherapy
  • A large national screening trial of more than 50,000 current and former heavy smokers that found three annual low-dose computed tomography (CT) scans reduced the death rate from lung cancer by 20 percent compared to those who were screened with three annual chest X-rays
  • FDA approvals on therapies for two hard-to-treat cancers:
    • Crizotinib (Xalkori) was approved for patients with advanced non-small-cell lung cancer who harbor a specific type of alteration in the anaplastic lymphoma kinase (ALK) gene based on the results from two Phase II studies: one study demonstrated that 50 percent of patients experienced complete or partial tumor shrinkage for a median of 10 months and a second study found a 61 percent objective response rate lasting a median of 12 months
    • Ipilimumab (Yervoy) -- an immune therapy that activates the immune system's T cells -- was approved for patients with previously untreated metastatic melanoma based on the results of a Phase III trial showing that the drug, combined with the standard chemotherapy drug dacarbazine, improved overall survival by two months
  • The first conclusive evidence that an aromatase inhibitor reduced the risk of a first breast cancer, making exemestane (Aromasin) a preventative treatment option for postmenopausal women who are at high risk for the disease

Selected by an 18-person editorial board of prominent oncologists, the report highlights a total of 54 advances in clinical oncology over the past year and covers the full scope of patient care, including cancer disparities, advanced cancer care and survivor care.

Clinical Cancer Advances 2011 also features a "Year in Review" section, which describes key cancer policy developments and ASCO policy initiatives from the past year that are likely to influence cancer care over the coming years. Some of the important topics covered in this section include:

  • ASCO's recommendations for re-vitalizing U.S. clinical cancer research for the molecular era, captured in the new report, Accelerating Progress Against Cancer: ASCO's Blueprint for Transforming Clinical and Translational Cancer Research
  • Efforts to address the growing problem of oncology drug shortages
  • The potential impact of healthcare reform in addressing cancer disparities

To download a full copy of the Clinical Cancer Advances 2011 report, visit: http://www.cancer.net/cca


Story Source:

The above story is based on materials provided by American Society of Clinical Oncology. Note: Materials may be edited for content and length.


Cite This Page:

American Society of Clinical Oncology. "American Society of Clinical Oncology issues annual report on progress against cancer." ScienceDaily. ScienceDaily, 5 December 2011. <www.sciencedaily.com/releases/2011/12/111205165859.htm>.
American Society of Clinical Oncology. (2011, December 5). American Society of Clinical Oncology issues annual report on progress against cancer. ScienceDaily. Retrieved April 19, 2014 from www.sciencedaily.com/releases/2011/12/111205165859.htm
American Society of Clinical Oncology. "American Society of Clinical Oncology issues annual report on progress against cancer." ScienceDaily. www.sciencedaily.com/releases/2011/12/111205165859.htm (accessed April 19, 2014).

Share This



More Health & Medicine News

Saturday, April 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Nine-Month-Old Baby Can't Open His Mouth

Nine-Month-Old Baby Can't Open His Mouth

Newsy (Apr. 19, 2014) Nine-month-old Wyatt Scott was born with a rare disorder called congenital trismus, which prevents him from opening his mouth. Video provided by Newsy
Powered by NewsLook.com
'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins